(Total Views: 77)
Posted On: 08/25/2021 10:55:48 AM
Post# of 145188

$RFL News Article - Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates Phase 2 for CPI-613 (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer https://marketwirenews.com/news-releases/rafa...89089.html


My Twitter: WhyteStocks